Airedale NHS Foundation Trust

West Yorkshire and Harrogate, Cancer Alliance

Management of High Grade Dysplasia patients

Time period: 2015-19
Cancer Alliance National
Number of High Grade Dysplasia patients in audit 28 1448
Cancer Alliance National
Method of Diagnosis
– First diagnosis confirmed by second pathologist 22 76.9% 86.9%
Treatment planning
– HGD plan discussed at MDT 25 89.3% 87.9%
– Treatment plan for active treatment 23 82.1% 81.1%
First treatment
– Endoscopic therapy (such as endoscopic resection) 23 82.1% 73.8%
– Surveillance 3 10.7% 11.0%

Management of oesophago-gastric cancer patients

Time period: 2017-2019
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 70 20528
Case ascertainment for OG cancer (%) 85-100%
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
10 15.8% 13.3%
– Patients with referral source reported as unknown 5 7.1% 1.8%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded 67 95.7% 86.9%
Treatment planning
– Patients having a plan for curative treatment 21 30.0% 38.5%
– Patients having a plan for non-curative treatment 49 70.0% 61.5%
– Patients with non-curative plans having chemotherapy or radiotherapy 13 26.5% 48.2%

Download this data as a PDF